SmileDirectClub opens trading 10% below the $23 a share pricing of its initial public offering.
SmileDirectClub's IPO fell flat, though the company still raised $1.3 billion.
The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.
We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.
CVS continues to move in the right direction for the bulls.
OxyContin maker Purdue Pharma has reached a partial, tentative multi-billion-dollar settlement in connection with the opioids crisis.
Have shares of this leading health benefits company bottomed?
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.